Choksi Asia Q1 FY27: Revenue down 22%, PAT down 10% YoY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.7 pts less than Nifty Microcap 250 and 5.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved standalone unaudited results for Q1 FY27 (quarter ended June 30, 2026). Revenue from operations fell to 922.10 lakhs from 1189.75 lakhs, down about 22.5 percent YoY. Profit after tax came in at 96.17 lakhs versus 107.43 lakhs, down around 10.5 percent. EPS stood at 1.69 versus 1.88. However, PBT edged up to 154.08 lakhs from 151.60 lakhs as cost discipline helped margins. Limited review by Karia and Shah was clean with no qualifications.
Sharp revenue drop YoY is a concern for shareholders, though margins held. Watch demand recovery and order flow in coming quarters.